Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure

Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure

Background: Growing evidence shows that impaired signaling of Insulin-like Growth Factor-1 (IGF-1) is associated with neurodegenerative disorders, such as Parkinson's disease (PD). However, there is still controversy regarding its proinflammatory or neuroprotective function. In an attempt to el...

Full description

Bibliographic Details
Main Authors: Farzaneh Ghazi Sherbaf, Bahram Mohajer, Amir Ashraf-Ganjouei, Mahtab Mojtahed Zadeh, Ali Javinani, Hossein Sanjari Moghaddam, Mehdi Shirin Shandiz, Mohammad Hadi Aarabi
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Endocrinology
Subjects:
Parkinson's disease
insulin-like growth factor-1
connectometry
diffusion tensor imaging
synuclein
amyloid
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00608/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2018.00608/full

Similar Items